DME Capital Management’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$106M Buy
4,518,381
+397,178
+10% +$7.19M 3.31% 7
2025
Q4
$58.5M Buy
4,121,203
+2,478,493
+151% +$46.9M 2.05% 15
2025
Q3
$40.7M Buy
1,642,710
+777,699
+90% +$17.4M 1.6% 19
2025
Q2
$19.6M Buy
865,011
+744,151
+616% +$17.6M 0.84% 21
2025
Q1
$3.66M Sell
120,860
-7,780
-6% -$296K 0.19% 26
2024
Q4
$5.1M Buy
+128,640
New +$5.8M 0.26% 25

Other funds holding ACHC

DME Capital Management's ACHC Position: Q1 2026 in Review

DME Capital Management increased its Acadia Healthcare (ACHC) stake by 9.6% in Q1 2026, buying an estimated $7.19M and bringing the position to 4,518,381 shares worth $106M. The position accounts for 3.31% of the portfolio, ranked #7.

DME Capital Management first reported a position in ACHC in Q4 2024 and has held it in 6 quarters since. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • DME Capital Management held 4,518,381 shares of Acadia Healthcare worth $106M as of Q1 2026.
  • DME Capital Management bought 397,178 Acadia Healthcare shares in Q1 2026, an estimated $7.19M.
  • Acadia Healthcare made up 3.31% of DME Capital Management's portfolio in Q1 2026, its #7 holding.
  • DME Capital Management first reported a position in Acadia Healthcare in Q4 2024 and has held it in 6 quarters since.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on DME Capital Management's 13F filing for Q1 2026, filed 15 May 2026.